{{noteTA
|1=zh-cn:非甾体;zh-tw:非類固醇;
|2=zh-cn:抗炎药;zh-tw:消炎止痛藥;
}}
{{medical}}
{{unreferenced|time=2010-01-03T09:19:59+00:00}}
{{drugbox
| IUPAC_name = 4-hydroxy-2-methyl-''N''-(5-methyl-2-thiazolyl)-2''H''-1,2-benzothiazine-3-carboxamide-1,1-dioxide<br />4-羟基-2-甲基-N-(5-甲基-1,3-噻唑-2-基)-2H-1,2-苯并噻嗪-3-甲酰胺-1,1-二氧化物
| image = Meloxicam.svg
| width = 250
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 71125-38-7
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 10442740
| ATC_prefix = M01
| ATC_suffix = AC06
| PubChem = 5281106
| DrugBank_Ref = {{drugbankcite|changed|??}}
| DrugBank = APRD00529
| DrugBank2_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank2 = DB00814
| IUPHAR_ligand = 7220
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = VG2QF83CGL
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00969
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 6741
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 599
| PDB_ligand = MXM
| C = 14 | H = 13 | N = 3 | O = 4 | S = 2
| molecular_weight = 351.403 g/mol
| smiles = Cc1cnc(s1)NC(=O)C1=C(O)c2ccccc2S(=O)(=O)N1C	
| bioavailability = 89%
| protein_bound = 99.4%
| metabolism = [[肝脏|肝脏]] (由[[CYP2C9|CYP2C9]]和[[CYP3A4|3A4]]介导)
| elimination_half-life = 15～20小时
| excretion = 尿液、粪便 (约等量)
| pregnancy_US = C
| pregnancy_category = D in third trimester
| legal_US = Rx-only
| legal_UK = POM
| routes_of_administration = 口服
}}

'''美洛昔康'''（Meloxicam），商品名'''莫比可'''（Mobic），是一种[[昔康|昔康]]（oxicam）类[[非甾体抗炎药|非甾体抗炎药]]，可抑制[[环氧酶|环氧酶]]的活性，从而阻断[[前列腺素|前列腺素]]的合成。主要用于缓解骨关节炎、类风湿性关节炎及关节强硬性脊椎炎的症状。

{{Anti-inflammatory products}}

[[Category:非甾体抗炎药|Category:非甾体抗炎药]]
[[Category:噻唑|Category:噻唑]]